- Neuro-All - University of Manitoba Mailing Lists

New MNN visual identity
by Chris Anderson 27 Jan '16

27 Jan '16

Dear All, As you know, a major Manitoba Neuroscience Network project is underway to bring Manitoba neuroscientists with diverse departmental and institutional affiliations together under a virtual institute umbrella. The objective is to create a unified representation of expertise, quality and opportunity in neuroscience research here. A comprehensive MNN website is under construction. Along with the website, a new visual identity has been created to begin to cultivate a unified and consistent perception of our people and research. We are ready to start rolling-out the new identity. Here are a few things to know: * The Winnipeg Chapter of the Society for Neuroscience will continue to operate as a local SFN Chapter with full rights and responsibilities. However, the Chapter will now be named, "Manitoba Neuroscience Network." This organizational simplification will allow full incorporation of all networking and outreach elements, including current WCSN website content, into the new presentation. A special thank you to Gilles Detillieux for maintaining the current website so consistently over the years, and for agreeing to help with content for the new site. Once ready, the new website will be at www.manitobaneuroscience.ca<http://www.manitobaneuroscience.ca>. * Going forward, all MNN networking and outreach materials will reflect the new visual identity. This includes meeting posters, seminar schedules, emails, reports, social media and of course the website. ****Watch for the 2016 scientific meeting SAVE THE DATE announcement later this week.**** The identity was created professionally with input from a committee of our peers. The committee was created by a call for volunteers about a year ago and I thank those who stepped forward. We are fully aware that not everyone likes the same sorts of design, but the committee went through many concepts and eventually agreed on the basic framework you will see. I'm hopeful we can all stand behind it going forward. * Future emails will come from the new MNN email domain. For matters related to networking the email address will be networking(a)manitobaneuroscience.ca<mailto:networking@manitobaneuroscience.ca>; for matters related to outreach the address will be outreach(a)manitobaneuroscience.ca<mailto:outreach@manitobaneuroscience.ca>. Be sure these addresses won't be filtered to avoid missing important information. * We have over 60 PIs who have already asked to be profiled on the website. If you are not one of them and would like to be, please email networking(a)manitobaneuroscience.ca<mailto:networking@manitobaneuroscience.ca>. * Finally, we are active social media participants. If you are too, don't forget to follow MNN on Twitter (@manitobaneuro) and Instagram (@manitobaneuroscience), and like us on Facebook (www.facebook.com/manitobaneuroscience). If you have any material for distribution by social media (announcements, polls, news, congratulations, papers, meetings, social events etc), email to networking(a)manitobaneuroscience.ca<mailto:networking@manitobaneuroscience.ca>. Thank you for being active members of the MNN and for participating in MNN events. With partners, your dues and participation have made our growth possible. Sincerely, MNN leaders Partners: University of Manitoba Faculties, Departments and Programs, Winnipeg Health Sciences Centre, Health Sciences Centre Foundation, St. Boniface Hospital Research, Research Manitoba, Society for Neuroscience.

1 0

Reminder : Tomorrow Friday Jan 22 @12:00Noon Tabrez Siddiqui
by Winnipeg Chapter Society for Neuroscience 21 Jan '16

21 Jan '16

Everyone is invited! Department of Pharmacology & Therapeutics Seminar Series: Date: Friday, January 22, 2016 Time: 12:00 Noon Location: 626 Basic Medical Sciences Building Tabrez J. Siddiqui, PhD <http://umanitoba.ca/faculties/health_sciences/medicine/units/physiology/con…> Principal Investigator, Neuroscience Research Program, Kleysen Institute for Advanced Medicine, Health Sciences Centre and University of Manitoba Assistant Professor of Physiology and Pathophysiology, University of Manitoba Topic: "Molecular mechanisms of cell-selective synapse development" Kelly Jorundson Administrative Manager Division of Neurodegenerative Disorders Albrechtsen Research Centre, St. Boniface Hospital & Department of Pharmacology & Therapeutics College of Medicine, Faculty of Health Sciences University of Manitoba Room R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 | Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR Kelly.Jorundson(a)umanitoba.ca

1 0

MNN Seminar - Friday Jan 29th @ 9am | Dr. Soheila Karimi
by Winnipeg Chapter Society for Neuroscience 21 Jan '16

21 Jan '16

Please circulate! Manitoba Neuroscience Network 2015/2016 Seminar & Visiting Speaker Series Friday, January 29th, 2016 | 9:00 a.m. Soheila Karimi, PhD <http://home.cc.umanitoba.ca/~karimis/> Assistant Professor of Physiology and Pathophysiology Senior Scientist, Regenerative Medicine Program Principal Investigator, Spinal Cord Research Center Scientist, Children's Hospital Research Institute of Manitoba Faculty of Health Sciences, College of Medicine University of Manitoba Topic: Neuregulin-1 a multifaceted therapeutic target for CNS repair and regeneration Location: PX236/238 Psych Bldg., Bannatyne Campus Biosketch: Soheila Karimi has had a long-term interest in spinal cord regeneration with a special focus on developing pharmacological and stem cell therapies for promoting myelin repair following injury. Soheila received her PhD degree in Neurosciences with David Schreyer in the Department of Anatomy and Cell Biology at the University of Saskatchewan in 2001. She then undertook a postdoctoral fellowship in Spinal Cord Injury and Stem Cell Research with Michael Fehlings at the Toronto Western Research Institute and the University of Toronto. During her training, Soheila received numerous academic and research awards including postdoctoral fellowships from the CIHR, Ontario Neurotrauma Foundation and the Heart and Stroke Foundation. Her postdoctoral work broke a new ground in spinal cord injury therapeutics by showing that transplantation of adult neural stem cells can be used therapeutically to replace lost oligodendrocytes and functionally restore myelin with improved recovery of function. In 2006, she received the prestigious Synthes Award from the American Association of Neurological Surgeons in the US for this work. Prior to joining the University of Manitoba in 2010, Soheila was an adjunct Assistant Professor at the University of Toronto from 2007 to 2009. Research Interests: Current research in Karimi's laboratory continues to focus on developing regenerative medicine strategies for promoting myelin repair and functional recovery in spinal cord injury and multiple sclerosis. Using drug delivery, stem cell transplantation and bioengineering approaches in pre-clinical models, Karimi's team has recently discovered key factors that play major roles in regulating the proliferation and differentiation of neural stem cells in CNS injury. Elucidating the underlying mechanisms of stem cell functions is vital in identifying potential therapeutic targets for enhancing cell tissue reconstruction after injury. For more information, contact the MNN Office at (T) 235.3939 or email: mnn(a)sbrc.ca Our Partners: Winnipeg Chapter Society for Neuroscience Division of Neurodegenerative Disorders, St. Boniface Albrechtsen Research Centre Neuroscience Research Program, Health Sciences Centre & University of Manitoba Kelly Jorundson Administrative Manager Division of Neurodegenerative Disorders Albrechtsen Research Centre, St. Boniface Hospital & Department of Pharmacology & Therapeutics College of Medicine, Faculty of Health Sciences University of Manitoba Room R4046 - 351 Taché Avenue Winnipeg, MB R2H 2A6 CANADA Tel: 204.235.3939 | Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR Kelly.Jorundson(a)umanitoba.ca

1 0

Dr. Patrick Choy Distinguished Lectureship: Dr. Stephen Collins Jan 14th 11am | Theatre A
by Winnipeg Chapter Society for Neuroscience 12 Jan '16

12 Jan '16

Everyone is invited..... The Dr. Patrick Choy Distinguished Lecture Dr. Stephen Collins Associate Dean, Research Faculty of Health Sciences McMaster University Microbes, the Gut and the Brain: A bedside to bench approach to understanding functional intestinal disorders Thursday, January 14, 2016 11:00 a.m. Frederic Gaspard Theatre (Theatre A), Basic Medical Sciences Building http://events.umanitoba.ca/EventList.aspx?fromdate=1/14/2016&todate=1/14 /2016&display=Day&type=public&eventidn=11035&view=EventDetails&informati on_id=22762 Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Reminder: Manitoba Neuroscience Network Visiting Speaker Lecture - Dr. Tim Kennedy - Jan 15 3pm
by Winnipeg Chapter Society for Neuroscience 11 Jan '16

11 Jan '16

Manitoba Neuroscience Network 2015/2016 Seminar & Visiting Speaker Series Friday, January 15th, 2016| 3:00 p.m. Timothy Kennedy Professor - Department of Neurology & Neurosurgery co-Director - McGill Program in NeuroEngineering Montreal Neurological Institute McGill University TOPIC: Making Connections: New Roles for Netrin-1 and DCC Regulating Myelination, Synaptogenesis, and Plasticity Location: Theatre C, Bannatyne Campus My undergraduate studies were carried out at McMaster University in the Biology and Psychology program. I then trained as a graduate student from 1985 to 1992 in the department of Physiology and Cellular Biophysics at Columbia University under the supervision of Dr. Eric R. Kandel, investigating molecular mechanisms that underlie learning and memory. During this time, my colleagues and I identified changes in protein and mRNA expression associated with long-term memory formation. Our findings indicated that neuromodulatory changes underlying learning evoke changes in gene expression. From 1992 to 1996 I was a post-doctoral fellow with Dr. Marc Tessier-Lavigne at UCSF. My colleagues and I purified and cloned a family of proteins that we named netrins, which were the first identified long-range chemoattractant axon guidance cues. Netrins perform and essential, highly conserved role, directing axon extension during neural development. In 1996 I opened my laboratory at the Montreal Neurological Institute. We are currently investigating the cellular and molecular mechanisms that underlie axon extension, myelination, synapse formation, and synaptic plasticity. Broadly stated, we are interested in the signals that direct cells and axons to move, and once they reach their goal, the target derived signals that instruct them to stop and sustain an appropriate connection with a neighboring cell. In collaboration with other groups at the MNI, we are studying the significance of these mechanisms to neural development and to neurodegenerative disease. I am also co-director of the McGill Program in NeuroEngineering (www.neuroengineering.ca) which promotes collaboration between neuroscientists, physical scientists, and engineers with the aim of developing new tools to study the nervous system and enhance function following injury or in neurodegenerative disease. Website: https://www.mcgill.ca/neuro/research/researchers/kennedy Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Weston Brain Institute - New Funding Opportunity - Canada: Rapid Response 2016
by Chris Anderson 05 Jan '16

05 Jan '16

From: Weston Brain Institute [mailto:neuro@weston.ca] Sent: Tuesday, January 05, 2016 12:06 PM Subject: Weston Brain Institute - New Funding Opportunity - Canada: Rapid Response 2016 [cid:image001.jpg@01D07D1A.DDCC4D80] Canada: Rapid Response 2016 Neurodegenerative Diseases of Aging The Weston Brain Institute is delighted to launch our Canada: Rapid Response 2016 program to provide seed funding for novel, high-risk, high-reward translational research. Additional information about the program can be found at http://westonbraininstitute.ca/rapid-response-2016/. NEW for 2016: The program will have 3 application rounds, focused on two different disease groups. Applicants should apply to the group best suited to their project. Each PI may submit one application per round as the Principal Applicant or the Administrative Supervisor. ________________________________ Goal: Provide seed funding for novel, high-risk, high-reward translational research ideas to catalyze the development of safe and effective treatments for neurodegenerative diseases of aging Funding: Up to $150,000 over up to 18 months Eligibility: Applicants must be researchers or postdoctoral fellows developing a therapeutic and/or a tool to help accelerate the development of therapeutics for neurodegenerative diseases of aging Disease Groups: AD-related diseases: AD, FTD, MCI and prodromals PD-related diseases: PD, PSP, LBD, MSA and prodromals Current Round: Round 1 (AD-related diseases) Program Information Session: Monday, Jan. 25th, 2016 1:00 p.m. EST Letter of Intent Deadline: Tuesday, Feb. 23th, 2016 2:00 p.m. EST Upcoming Rounds: Round 2 (PD-related diseases) Program Information Session: Tuesday, May 24th, 2016 1:00 p.m. EDT Letter of Intent Deadline: Monday, June 27th, 2016 2:00 p.m. EDT Round 3 (AD-related diseases) Program Information Session: Wednesday, July 6th, 2016 1:00 p.m. EDT Letter of Intent Deadline: Thursday, July 28th, 2016 2:00 p.m. EDT ________________________________ Submission of the Letter of Intent is through the Institute’s online grant management system at https://weston.smartsimple.ca/welcome/neuroscience. The Weston Brain Institute will be holding a Program Information Session for this funding opportunity on Monday January 25th, 2016 at 1:00p.m. EST. This session is intended to provide you with comprehensive information on the application process and to provide an opportunity for open questions. To sign-up for the information session and receive the dial in details, as well as submit any questions you may have in advance, please click the link below: https://attendee.gotowebinar.com/register/1793756835407375361 The Institute welcomes inquiries about our funding programs at neuro(a)weston.ca<mailto:neuro@weston.ca> or 416-935-4056. Weston Brain Institute This email message is confidential, may be legally privileged and is intended for the exclusive use of the addressee. If you received this message in error or are not the intended recipient, you should destroy the email message and any attachments or copies, and you are prohibited from retaining, distributing, disclosing or using any information contained. Please inform us of the delivery error by return email. Thank you for your cooperation. Le présent message électronique est confidentiel et peut être couvert par le secret professionnel. Il est à l’usage exclusif du destinataire. Si vous recevez ce message par erreur ou si vous n’en êtes pas le destinataire prévu, vous devez détruire le message et toute pièce jointe ou copie et vous êtes tenu de ne pas conserver, distribuer, divulguer ni utiliser tout renseignement qu’il contient. Veuillez nous informer de toute erreur d’envoi en répondant à ce message. Merci de votre collaboration.

1 0

MNN Speaker - Dr. Timothy Kennedy Friday, Jan 15, 2016 *3pm Theatre C
by Winnipeg Chapter Society for Neuroscience 16 Dec '15

16 Dec '15

Everyone is invited.... Manitoba Neuroscience Network 2015/2016 Seminar & Visiting Speaker Series Friday, January 15th, 2016 | 3:00 p.m. Timothy Kennedy <https://www.mcgill.ca/neuro/research/researchers/kennedy> Professor - Department of Neurology & Neurosurgery co-Director - McGill Program in NeuroEngineering Montreal Neurological Institute McGill University TOPIC: Making Connections: New Roles for Netrin-1 and DCC Regulating Myelination, Synaptogenesis, and Plasticity Location: Theatre C, Bannatyne Campus Visit Dr. Kennedy's Website to learn about his research: https://www.mcgill.ca/neuro/research/researchers/kennedy For more information, please contact the MNN Office at 204.235.3939 The 2015/2016 MNN Seminar & Visiting Speaker Series is funded by: * Winnipeg Chapter Society for Neuroscience - Manitoba Neuroscience Network * Division of Neurodegenerative Disorders, St. Boniface Hospital Albrechtsen Research Centre * Neuroscience Research Program, Health Sciences Centre & University of Manitoba Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Reminder: MNN Visiting Speaker - Friday Dec 11 @ **3pm - Theatre C Dr. Yu Tian Wang
by Winnipeg Chapter Society for Neuroscience 08 Dec '15

08 Dec '15

Everyone is invited to attend.... Manitoba Neuroscience Network 2015/2016 Seminar & Visiting Speaker Series Friday, December 11th, 2015 | 3:00 p.m. Yu Tian Wang <http://www.neuroscience.ubc.ca/people/Wang> Professor, Department of Medicine, Division of Neurology Chair in Stroke Research University of British Columbia TOPIC: Peptide-based research tools and therapeutics in the post-genome era Location: Theatre C, Bannatyne Campus Research Focus: I have a long-standing research interest in understanding the molecular mechanisms responsible for regulating the function and intracellular trafficking of neurotransmitter receptors critical for brain functions such as learning, memory and cognition, and investigating the manner by which these mechanisms may be altered in central nervous disease processes. My goal is to be able to treat central nervous disorders such as stroke, drug addiction, and schizophrenia by designing new therapeutics that specifically target these receptors and their pathways. With particular relevance to this project, we have made a significant impact on stroke research. We discovered that NMDA receptor NR2A and NR2B subunits have respective roles in promoting cell survival and cell death (J. Neurosci. 27:2846, 2007). We have characterized the molecular steps downstream of the NR2B death pathway, and also developed several specific inhibitors to disrupt this pathway and demonstrated their therapeutic potentials in reducing brain damage following stroke (Science 298:846, 2002; JBC 279:41267, 2004; Nature Med. 15:1399, 2009; J. Neurosci. 33:7997, 2013). To translate these basic scientific discoveries into potential therapeutics for brain dysfunctions, I founded, along with five other scientists/clinicians, the NoNO Inc. in Toronto that has recently completed a successful phase 2 clinical trial, demonstrating for the first time a clinically effective neuroprotectant NA-1 (Tat-NR2B9c) in reducing ischemic brain damage (Lancet Neurol 11:942, 2012). Our research expertise spans functionally characterizing synaptic plasticity, biochemically mapping protein-protein interaction sites, and designing specific peptides for use in models of CNS disorders. Kelly Jorundson Winnipeg Chapter Society for Neuroscience R4046 - 351 Tache Avenue Winnipeg, MB R2H 2A6 Tel: 204.235.3939 Fax: 204.237.4092 Email: kjorund(a)sbrc.ca OR kjorund(a)yahoo.ca Website: www.sfn-manitoba.ca

1 0

Recall: Reminder: Friday - Dec 4th 9am - MNN Speaker - Dr. Chris Proschel
by Winnipeg Chapter Society for Neuroscience 01 Dec '15

01 Dec '15

Winnipeg Chapter Society for Neuroscience would like to recall the message, "Reminder: Friday - Dec 4th 9am - MNN Speaker - Dr. Chris Proschel".

1 0

Reminder: Friday - Dec 4th **12noon** - MNN Speaker - Dr. Chris Proschel
by Winnipeg Chapter Society for Neuroscience 01 Dec '15

01 Dec '15

Please note lecture starts at 12noon. Manitoba Neuroscience Network 2015/2016 Seminar & Visiting Speaker Series Friday, December 4th, 2015 | 12:00 Noon Christoph J.W. Pröschel <https://www.urmc.rochester.edu/labs/proschel-lab/> Associate Professor of Genetics University of Rochester Medical Center, Department for Biomedical Genetics, Stem Cell and Regenerative Medicine Institute Pathways of Human Disease Program TOPIC: Glial cell therapy: the opportunity for restoring function by restoring tissue homeostasis. Location: Theatre C, Bannatyne Campus Within the context of our work on glial progenitor cells, we are now focusing on the role of astrocytes as critical modulators in response to injury or stress. The importance of understanding this process is emphasized by our discovery that the generation of mature astrocytes may be impaired in Vanishing White Matter leukodystrophy (Nat Med. 2005 Mar;11(3):277-83.). The ability to study astrocyte development in normal and pathological conditions, provides a unique opportunity to test the utility of glial precursor cells and their astrocytic progeny for cell transplantation therapy in diseases of the central nervous system (CNS), such as traumatic injury (spinal cord and traumatic brain injury) and neurodegenerative diseases (Parkinsons Disease, Multiple sclerosis). We have identified distinct astrocyte populations that demonstrate different functional properties with respect to their ability to promote injury repair upon transplantation into the injured nervous system. While one type shows little benefit and may even cause neuropathic pain syndrome, the other remodels the injured host tissue, enables axon outgrowth and extensive functional recovery (J Biol 2006 Apr 27, 5(3):7; J Biol 2008 Sep 19;7(7):245). As a prerequisite for the transition to the clinic we are analyzing the factors secreted by these astrocytes and have now derived homologous astrocyte populations from human precursor cells. (PLoS One. 2011 Mar 2;6(3)). For more information, contact the MNN Office at (T) 235.3939 or email: mnn(a)sbrc.ca

1 0